You Are Browsing ‘Health’ Category

Ardelyx Inc (NASDAQ:ARDX) To Repurchase Troubled Sodium Drug From Astrazeneca Plc (ADR) (NYSE:AZN)

health

Ardelyx Inc (NASDAQ:ARDX) has decided to buy out of its partnership with AstraZeneca plc (ADR) (NYSE:AZN) after their joint efforts in its lead drug, didn’t go so well. Ardelyx will give AstraZeneca an initial $15 million and $10 million in form of research and development costs. AtraZeneca entered into…

More…
MED

New Micro Pacemaker From Medtronic PLC (NYSE:MDT) Could Be The Game Changer

Decades after Earl Bakken came up with the first pacemaker in the 60s, Medtronic PLC (NYSE:MDT) has introduced a considerably smaller pacemaker that could…

Gilead Sciences Inc.

Gilead Sciences, Inc. (NASDAQ:GILD) Announces $100 Million Investment To Expand Its Presence In Canada

American biopharmaceutical giant company, Gilead Sciences, Inc. (NASDAQ:GILD) reported it will invest an additional capital of $100 million to expand its…

MED

Medtronic PLC (NYSE:MDT) On The Search For Deals In China

Medtronic PLC (NYSE:MDT) is increasing the number of affordable medical services that it offers in the Chinese market as well as potentially lucrative…

pfizer

Deutsche Bank claims Pfizer Inc. (NYSE:PFE) Would Benefit From Glaxo Buyout

An analyst from a Deutsche Bank stated that Pharmaceutical company Pfizer Inc. (NYSE:PFE), would reap a lot of benefits if it were to acquire its rival…

johnson-and-johnson

Johnson & Johnson (NYSE:JNJ) Invests In Alzheimer’s, Cancer As Competitive Threats Continues To Grow

Johnson & Johnson (NYSE:JNJ) has started casting out its investment net over various potentially successful drug treatments for popular conditions…

merck-pills

Merck & Co., Inc. (NYSE:MRK) Could Struggle To Hit Health Care Heights

German health care company Merck & Co., Inc. (NYSE:MRK) has high hopes on its mission to successfully develop its anti-PDL1 immuno- oncology treatment…

alexion-pharmaceuticals

Armistice Activists Demand New Buyer, CEO for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

Steve Boyd’s Hedge fund Armistice Capital had demanded the Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to dump its CEO and find a new buyer quickly….

biopharmaceutical

PlasmaTech Biopharmaceuticals, Inc. (NASDAQ:PTBI) Appoints Todd Wider as MD

PlasmaTech Biopharmaceuticals, Inc. (NASDAQ:PTBI) has announced that the appointment of Todd Wider as the MD of the Board of Directors. The focus of this…

pharma

La Jolla Pharmaceutical Company (NASDAQ:LJPC) Halts GCS-100 And LJPA-1010 Trials On FDA Concerns

La Jolla Pharmaceutical Company (NASDAQ:LJPC) has brought to halt, the clinical trials of the GCS-100 and the LJPA-1010 drugs due to the strict regulations…

1 2 3 4 5 6 7 8 9 … 44

SPYR banner1